Connect Biopharma Faces Financial Hurdles Amid Clinical Advances in 2025
Connect Biopharma Holdings Ltd navigates financial challenges and regulatory hurdles as it advances its clinical pipeline for T cell-driven inflammatory diseases, including COPD and asthma treatments.
- Connect Biopharma Holdings Ltd
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read